By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Optivia Biotechnology today announced it has been awarded a $1.9 million Phase II Small Business Innovation Research grant to "determine the precise mechanisms that underlie certain drug-to-drug interactions," in an effort to improve medication safety.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Dog DNA testing finds that some purebreds might not truly be purebreds, Inside Edition reports.

Mary Beckerle has returned as director of the Huntsman Cancer Institute, according to ScienceInsider.

Smithsonian Magazine reports that environmental DNA sampling can be used to track elusive organisms.

In Genome Research this week: repetitive satellite DNA in the fruit fly, transcriptome map assembly pipeline, and more.